Proscia

Proscia - Digital Pathology AI

Proscia Introduces AI-Powered Quality Control to Accelerate Data-Driven Drug Development

Application paves the way for digital pathology’s first suite of process automation solutions and launches alongside new version of the Concentriq for Research platform May 17, 2022 08:00 AM Eastern D...

Digital Pathology - Proscia Siemens

Proscia-Siemens Healthineers: A win-win deal set to shake-up Digital Pathology?

The recent news that digital pathology pioneer Proscia and the multi-billion-dollar healthcare giant Siemens Healthineers had inked a multi-year OEM agreement certainly raised industry eyebrows. For S...

AI-Powered Pathology to Drive Insight in Cancer Diagnosis

Driven by a growing base of evidence on the economic and clinical benefits of adoption, leading laboratories are increasingly looking to adopt AI in routine practice to optimize operations and improve...

Siemens Proscia - Digital Pathology

Proscia and Siemens Healthineers Ink Agreement to Expand Global Reach of Digital Pathology

Siemens Healthineers expands its Enterprise Imaging offering with Proscia’s Concentriq Dx platform for digital pathology PHILADELPHIA – March 16, 2022 – Proscia®, the leader in digital and compu...

Proscia, Hama - digital pathology

Proscia and Hamamatsu Announce Collaboration to Accelerate Scaled Adoption of Digital Pathology

Proscia and Hamamatsu Announce Collaboration to Accelerate Scaled Adoption of Digital Pathology Cooperation agreement expands access to unified solution for end-to-end workflow   PHILADELPHIA – M...

Proscia Digital Pathology

Uppsala University Hospital Selects Proscia to Deliver Full-Scale Digital Pathology Adoption

Multi-year agreement will power 100% digitization of Uppsala’s clinical workflow and future AI integrations    UPPSALA, Sweden & PHILADELPHIA, PA – February 3, 2022 – Proscia®, th...

Proscia - Digital Pathology

Proscia and Datavant Partner to Connect Pathology Data Ecosystem for Life Sciences R&D

Data accessibility and interoperability will accelerate translational medicine and development of therapeutic breakthroughs January 13, 2022, Philadelphia, PA and San Francisco, CA – Proscia, the lead...

  • 1
  • 2